Volatility has been the theme of 2026. The VIX touched 31.05 in late March before settling back to a current reading of 15.86, and the 10-year Treasury yield sits at 4.70%, near the top of its 12-month range. That backdrop shifts the calculus for income investors. When the risk-free rate is competitive, dividend stocks must earn their keep with consistency, coverage, and growth. The five names below share a common trait: multi-decade dividend streaks that ride out cycles like the one we are in now.
These are compounders with 39 to 71 years of uninterrupted annual dividend growth, boring in the best possible way — not high-yield speculations. Here is why each merits a closer look this August.
Coca-Cola (KO)
Coca-Cola (NYSE:KO | KO Price Prediction) is the archetypal defensive dividend name, and the numbers back it up. The quarterly dividend of $0.53 was raised from $0.51 beginning in 2026, extending a streak that spans 64 years. Shares closed at $86.56 on August 4, up 25.48% year to date, with an annualized forward dividend of $2.12 and a yield near 2.37%.
Second-quarter results reinforced the thesis. Q2 2026 adjusted EPS of $0.97 beat the $0.9323 consensus on revenue of $13.38 billion, up 6.7% year over year, and management raised full-year guidance to comparable EPS growth of 9% to 10%. Coca-Cola Zero Sugar grew 16%, and the FIFA World Cup 2026 marketing push should juice volume into year-end.
Risk: The stock trades at 26 times trailing earnings, a premium to its historical average, and Asia Pacific price/mix declined 9% last quarter. The premium valuation limits the margin of safety at current levels.
McDonald’s (MCD)
McDonald’s (NYSE:MCD) is the contrarian pick of the group. Shares are down 11.12% year to date, closing at $268.34, which pushes the yield up to 2.74%. The quarterly payout of $1.86 was raised from $1.77 in late 2025, marking its 49th consecutive annual increase and putting the company one hike away from formal Dividend King status.
The Q2 2026 report on August 4 delivered adjusted EPS of $3.38, beating the $3.32 estimate, with global comparable sales up 1.3% and nearly 220 million 90-day active loyalty users driving over $40 billion in trailing systemwide sales. Management is targeting 50,000 global units by 2028. Analyst target price of $323.58 implies material upside.
Risk: US guest counts turned negative and China and France posted negative comps. If a lower-income consumer slowdown deepens, traffic recovery gets pushed out.
Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) delivers a 64-year streak of increases. The board raised the quarterly payout to $1.34 in the May 2026 ex-dividend cycle, up from $1.30. Shares closed at $254.93, gaining 24.56% year to date and 52.77% over the past year.
Q1 2026 revenue of $24.06 billion grew 9.9%, and management raised full-year guidance to revenue of $100.3 billion to $101.3 billion. Innovative Medicine grew 11.2%, with DARZALEX at $3.96 billion up 22.5% and TREMFYA up 68.3%. CEO Joaquin Duato said "Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact."
Risk: STELARA is running off at a 59.7% decline as biosimilars take share, and legal reserves remain lumpy.
Chevron (CVX)
Chevron (NYSE:CVX) is the highest yielder in the group at 3.55%, with a quarterly dividend of $1.78, raised from $1.71 in early 2026, extending its 39-year streak of consecutive increases. Shares are up 27.3% year to date to $190.40.
Q2 2026 delivered adjusted EPS of $6.06, revenue of $67.2 billion up 51.4% year over year, and free cash flow of $18.1 billion. Worldwide production climbed 20% to 4,070 MBOED post-Hess, and management pulled forward $3 billion in annual run-rate cost reductions six months ahead of schedule. The recently announced 20-year, 2.67 GW power purchase agreement with Microsoft in West Texas gives Chevron a data center demand tailwind that competitors lack. Next ex-dividend date is August 19, with payment on September 10.
Risk: Oil is cyclical. A sharp drop in crude flips the free cash flow story quickly.
Procter & Gamble (PG)
Procter & Gamble (NYSE:PG) owns the longest streak in the group: 71 consecutive years of dividend increases. The current quarterly payout is $1.0885, up from $1.0568 earlier in 2026, yielding 2.95% on a share price of $148.01. Management plans to return roughly $10 billion in dividends and $5 billion in buybacks in FY2027.
Q4 FY2026 core EPS of $1.43 beat the $1.407 estimate, and full-year free cash flow reached $15.84 billion. Beauty led the quarter with 6% growth. With a net debt/EBITDA ratio of 1.2x and a beta of 0.377, this is as defensive as blue chips get.
Risk: Management flagged a ~$1 billion after-tax commodity, energy, and transport headwind in FY27, an 8% drag on EPS growth. Organic sales were flat in Q4, so patience is required.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks